Mingjie Shi

机构：Guangdong Medical College, Foshan Maternity and Child Health Care Hospital · ORCID：0000-0002-4338-4142

发表论文 27 篇 · 总被引 512 次 · h-index 13

代表论文

• Liposomal Codelivery of Doxorubicin and Andrographolide Inhibits Breast Cancer Growth and Metastasis (2018 · Molecular Pharmaceutics · 被引 71)
• Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide (2018 · Journal of Controlled Release · 被引 69)
• Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona (2021 · Acta Pharmaceutica Sinica B · 被引 53)
• Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles (2021 · Acta Pharmaceutica Sinica B · 被引 43)
• Estrogen receptor-regulated SOCS3 modulation via JAK2/STAT3 pathway is involved in BPF-induced M1 polarization of macrophages (2020 · Toxicology · 被引 40)
• Nano-Structural Effects on Gene Transfection: Large, Botryoid-Shaped Nanoparticles Enhance DNA Delivery via Macropinocytosis and Effective Dissociation (2019 · Theranostics · 被引 37)